risperidone / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 5 Diseases   67 Trials   67 Trials   4402 News 


«12...4849505152535455565758...6364»
  • ||||||||||  risperidone / Generic Mfg., Egis
    Clinical, Review, Journal:  Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences. (Pubmed Central) -  Sep 26, 2019   
    We also introduce relatively new concepts like biased agonism, receptor dimerization and neurogenesis to identify better the old and new hallmarks of "atypia". Finally, a detailed confrontation of clinical differences among the AAPs is presented, especially in relation to their molecular targets, and new means like therapeutic drug monitoring are also proposed to improve the effectiveness of AAPs in clinical practice.
  • ||||||||||  risperidone / Generic Mfg., Egis
    Drug-induced dystonia (Les Muses Terrace, Level 3) -  Sep 24, 2019 - Abstract #MDSCongress2019MDS_2164;    
    Clinical distribution is mainly cranial, but can be generalized. Benzodiazepines and anticholinergics are an effective treatment
  • ||||||||||  risperidone / Generic Mfg., Egis, Gablofen (baclofen) / Mallinckrodt
    Improvement of lower extremity Holmes tremor with intrathecal baclofen: First Report (Les Muses Terrace, Level 3) -  Sep 24, 2019 - Abstract #MDSCongress2019MDS_2008;    
    Weiss N et al described incidental improvement of upper extremity cerebellar intentional tremor after baclofen pump was implanted for spasticity [6].Our case is the first to demonstrate responsiveness of atypical Holmes tremor to ITB. ITB pump may be a promising neuromodulation option for medically-refractory atypical Holmes tremor of the lower extremity.
  • ||||||||||  risperidone / Generic Mfg., Egis, olanzapine / Generic Mfg., quetiapine / Generic Mfg.
    Patterns of Lewy body dementia diagnosis and treatment in Florida (Les Muses, Level 3) -  Sep 24, 2019 - Abstract #MDSCongress2019MDS_1678;    
    African-Americans account for a lower percent of LBD cases than the proportion of African-Americans (17%) in Florida suggesting LBD may be underdiagnosed in this population [1]. Opportunities to improve care include diagnosis amongst racial/ethnic minorities and decreased use of inappropriate antipsychotics.
  • ||||||||||  risperidone / Generic Mfg., Egis, quetiapine / Generic Mfg.
    Antipsychotics Use in Parkinson’s Disease and Mortality Risks (Les Muses, Level 3) -  Sep 24, 2019 - Abstract #MDSCongress2019MDS_1379;    
    Antipsychotic medication, particularly quetiapine, is commonly prescribed for PD in Taiwan, despite the black-box warning. The cause of higher mortality risks among antipsychotics users in PD warrants further investigation.
  • ||||||||||  aripiprazole / Generic Mfg., risperidone / Generic Mfg., Egis, quetiapine / Generic Mfg.
    Drug-Induced Parkinsonism May Persist Beyond Two Years After Discontinuation of Dopamine Transmission Blocking Agents (Agora 2 West, Level 2) -  Sep 24, 2019 - Abstract #MDSCongress2019MDS_1143;    
    Parkinsonism persisted at our last visit but improved during longitudinal follow-up, going against a progressive degenerative disorders such as Parkinson’s disease. DaT scans showing normal dopamine transporters at 8 and 16 months since discontinuation of causative agents persuade us that the patients did not evolve or concurrently suffer from neurodegenerative causes of parkinsonism.
  • ||||||||||  risperidone / Generic Mfg., Egis
    Re-emerging Neuroleptic Malignant Syndrome (NMS) without Re-introduced Neuroleptic in a Schizophrenia Patient: a Case Report (Agora 2 West, Level 2) -  Sep 24, 2019 - Abstract #MDSCongress2019MDS_830;    
    The patient was diagnosed with NMS and treated with bromocriptine...This case report shows that re-emerging NMS without any re-introduced neuroleptic drugs may be possible due to long-acting properties of neuroleptics injection. It is important for clinicians to be aware that the long-acting typical neuroleptic injection could cause prolonged effect to have an early identification and intervention
  • ||||||||||  Use of Inappropriate Antipsychotics Among US Long-Term Care Residents with Parkinson’s Disease Psychosis (Agora 3 West, Level 3) -  Sep 24, 2019 - Abstract #MDSCongress2019MDS_421;    
    Currently, pimavanserin is the only therapy approved for hallucinations and delusions in PDP, but second-generation AP therapies are frequently used, off label, for the treatment of PDP, including quetiapine and clozapine, the latter of which is associated with burdensome monitoring (3)...The relative rates in AP use was similar in the other database: quetiapine (57.0%), risperidone (24.6%), olanzapine (17.2%), aripiprazole (9.1%), and haloperidol (20%)...A high percentage of non-indicated APs are prescribed in LTC to treat PDP despite equivocal efficacy and questionable safety, especially, haloperidol, a first-generation AP (4). These data highlight the need for increased awareness of appropriate AP selection to support optimal treatment of LTC PDP residents.
  • ||||||||||  risperidone / Generic Mfg., Egis, olanzapine / Generic Mfg.
    Journal, HEOR:  Cost analysis study of neuropsychiatric drugs: Role of National List of Essential Medicines, India. (Pubmed Central) -  Sep 22, 2019   
    Antipsychotic medications and drugs for OCD in the NLEM group have a wider range than in the NNLEM group. The NLEM group has economical drugs in some disease categories; there is a need to consider the cost effectiveness of all drug categories while revising the NLEM next time and attention should focus on drug price regulation policies to accomplish the goal of rational use of medicines.
  • ||||||||||  risperidone / Generic Mfg., Egis
    Journal:  Risperidone induced rabbit syndrome. (Pubmed Central) -  Sep 20, 2019   
    The NLEM group has economical drugs in some disease categories; there is a need to consider the cost effectiveness of all drug categories while revising the NLEM next time and attention should focus on drug price regulation policies to accomplish the goal of rational use of medicines. No abstract available
  • ||||||||||  risperidone / Generic Mfg., Egis
    Clinical, Journal:  Dopamine (DRD2) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with Schizophrenia. (Pubmed Central) -  Sep 18, 2019   
    DRD2 -141 C Ins/Del (n=310, Ins/Ins=177, Ins/Del+ Del/Del=133, OR 0.70, 95% CI 0.4-1.2 p 0.2), Taq1A (n=320, AA=35, AG=132, GG=153, p 0.2), HTR2A -1438 G/A (n=320, AA=39, AG=164, GG=117, p 0.2), HTR2A 102T/C (n=320, CC=115, CT=165, TT=40, p 0.1) HTR2C -759 C/T (females n=132, CC=65, CT+TT=67, OR 1.3, 95% CI 0.6-2.8, p 0.5; males n=186, C=120, T=66, OR 1.2, 95% CI 0.6-2.4, p 0.4) genetic polymorphisms did not show any association with antipsychotic response to risperidone. DRD2 -141 C Ins/Del, Taq1A, HTR2A -1438 G/A, 102T/C and HTR2C -759 C/T genetic variants are not associated with antipsychotic response to risperidone.
  • ||||||||||  risperidone / Generic Mfg., Egis
    Biomarker, Clinical, Journal:  Plasma dopa decarboxylase activity in treatment-resistant recent-onset psychosis patients. (Pubmed Central) -  Sep 17, 2019   
    This may suggest that risperidone could influence plasma DDC activity. Based on these results, plasma DDC activity does not appear to be a promising biomarker for TR in recent-onset psychosis patients who are already receiving antipsychotic treatment.
  • ||||||||||  risperidone / Generic Mfg., Egis
    Clinical, Journal:  Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission? (Pubmed Central) -  Sep 14, 2019   
    Those who received a LAI with administration frequency of a month or longer had a significantly longer survival time without readmission (mean 307.9 days) when compared to those with a shorter administration frequency (mean 245.0 days). This study revealed the use of LAI antipsychotics in those with a history of medication non-adherence, particularly those with longer administration frequency, have potentially promising outcomes.
  • ||||||||||  risperidone / Generic Mfg., Egis
    Clinical, Journal:  A Case of Hyper Sexuality Probably Associated with Clozapine. (Pubmed Central) -  Sep 14, 2019   
    Due to non-compliance and relapse of symptoms, she was started on clozapine 450 mg which was further increased to 650 mg along with an injectable antipsychotic zuclopenthixol 400 mg...Poor understanding of the condition by the patient could lead to marital discord and suffering. WHO scale indicates clozapine as the probable cause of sexual dysfunction in our patient.
  • ||||||||||  risperidone / Generic Mfg., Egis, olanzapine / Generic Mfg.
    Journal, IO Biomarker:  Atypical antipsychotics induce human osteoblasts apoptosis via Wnt/β-catenin signaling. (Pubmed Central) -  Sep 11, 2019   
    APs cause OB cells apoptosis relating to Wnt/β-catenin signaling while resevratrol could reverse this phenomenon. Our study could lay the foundation for overcoming the APs-induced osteal side effects to improve the life quality of schizophrenia patients.
  • ||||||||||  risperidone / Generic Mfg., Egis, olanzapine / Generic Mfg., carbamazepine / Generic Mfg.
    Review, Journal:  Lithium for acute mania. (Pubmed Central) -  Sep 10, 2019   
    However, when compared to other drugs, too few studies provided data on adverse effects to provide high-certainty evidence. More, rigorously designed, large-scale studies are needed to definitively conclude if lithium is superior to other interventions in treating acute mania.
  • ||||||||||  risperidone / Generic Mfg., Egis, olanzapine / Generic Mfg.
    Seizures beyond epileptic seizures. () -  Sep 10, 2019 - Abstract #EUSEM2019EUSEM_1509;    
    In this case, the vascular and neoplastic causes were ruled out, with the CT scan of the skull; like the infectious and toxic cause was ruled out. The most successful possibility was the metabolic cause.
  • ||||||||||  risperidone / Generic Mfg., Egis, olanzapine / Generic Mfg.
    All excess is harmful, including water intake. () -  Sep 10, 2019 - Abstract #EUSEM2019EUSEM_1269;    
    The clinician may partially decrease these electrolyte disturbances and theirconsequences. It is necessary to strictly monitor the ions in patients with psychiatric disorders, provided that certain drugs are associated with their treatment.
  • ||||||||||  risperidone / Generic Mfg., Egis
    Clinical, Journal, Real-World Evidence:  Real-World Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder. (Pubmed Central) -  Sep 8, 2019   
    ...In comparison between use and no use among specific agents reaching nominal statistical significance, risperidone long-acting injection (HR, 0.58 [95% CI, 0.34-1.00]), gabapentin (HR, 0.58 [95% CI, 0.44-0.77]), perphenazine long-acting injection (HR, 0.60 [95% CI, 0.41-0.88]), and lithium carbonate (HR, 0.67 [95% CI, 0.60-0.73]) were associated with the lowest risk of psychiatric rehospitalization...The most frequently used antipsychotic treatment, quetiapine fumarate, showed only modest effectiveness (risk of psychiatric rehospitalization: HR, 0.92 [95% CI, 0.85-0.98]; risk of all-cause hospitalization: HR, 0.93 [95% CI, 0.88-0.98])...Results from sensitivity analyses showed consistent beneficial effects only for lithium and for long-acting injections compared with their oral counterparts. Lithium was the most effective mood stabilizer, and long-acting injections the most effective antipsychotics, in preventing hospitalization due to mental or physical illness.
  • ||||||||||  Saphris (asenapine) / Allergan, Lundbeck, Meiji Seika, risperidone / Generic Mfg., Egis, Geodon (ziprasidone) / RaQualia, Meiji Seika, Pfizer
    Clinical, Journal:  c-Fos expression in the hypothalamic paraventricular nucleus after a single treatment with a typical haloperidol and nine atypical antipsychotics: a pilot study. (Pubmed Central) -  Sep 7, 2019   
    These results suggested that both olanzapine and clozapine have antioxidative and antiapoptotic activities via distinct pathways, and provide useful information for better understanding of drug characteristics. The present pilot study revealed c-Fos expression increase predominantly in the PVN medial parvocellular subdivision neurons by action of only several sorts of antipsychotics tested indicating that this structure of the brain does not represent a common extra-striatal target area for all antipsychotics.
  • ||||||||||  risperidone / Generic Mfg., Egis, carbamazepine / Generic Mfg.
    Journal:  Pharmacotherapy of Down Syndrome. (Pubmed Central) -  Sep 6, 2019   
    If ineffective, we use memantine or clozapine...We treat "regression" with symptoms of MDD± psychosis, with an antidepressant and an antipsychotic if needed. Randomized controlled trials of medications for co-morbid psychiatric disorders in DS are warranted.
  • ||||||||||  risperidone / Generic Mfg., Egis
    Clinical, Journal:  Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics. (Pubmed Central) -  Sep 6, 2019   
    P1
    The treatment non-response at Week 2 optimally predicted the ultimate (Week 12) non-response, in terms of negative predictive value (NPV). These finding suggests that the revision of treatment strategy should be considered t if patients with schizophrenia was not responsive to them after 2 weeks' treatment, and for those who are responders at Week 2, another two weeks are needed to further evaluate whether they will be continuously responsive.
  • ||||||||||  risperidone / Generic Mfg., Egis
    Clinical, Journal:  The Impact of Antipsychotic Drugs on Long-term Care, Nursing Home Admission and Death among Dementia Patients. (Pubmed Central) -  Aug 30, 2019   
    In our study, APDs appeared to accelerate adverse health outcomes in German dementia patients. Differentiating between the effect of antipsychotic drug use among dementia patients residing in private households and in nursing homes, we found that excess mortality for haloperidol and melperone users was higher in private settings.
  • ||||||||||  risperidone / Generic mfg.
    Biomarker, Trial completion date, Trial primary completion date:  A Research in Pharmacogenomics and Accurate Medication of Risperidone (clinicaltrials.gov) -  Aug 29, 2019   
    P=N/A,  N=800, Recruiting, 
    Differentiating between the effect of antipsychotic drug use among dementia patients residing in private households and in nursing homes, we found that excess mortality for haloperidol and melperone users was higher in private settings. Trial completion date: Dec 2018 --> Jun 2020 | Trial primary completion date: Nov 2018 --> Jun 2020